Overview
Oligodendroglioma is a type of brain tumor that arises from the oligodendrocytes, which are the cells that produce myelin. Myelin is the fatty material that surrounds and insulates nerve fibers, allowing them to transmit electrical impulses quickly and efficiently. Oligodendrogliomas are classified as grade II or grade III based on their appearance under the microscope and how quickly they are likely to grow and spread. Grade II oligodendrogliomas are slow-growing and typically do not spread beyond the brain. Grade III oligodendrogliomas, on the other hand, are more aggressive and are more likely to infiltrate surrounding brain tissue. Symptoms of oligodendroglioma may vary depending on the location and size of the tumor, but may include headaches, seizures, problems with memory or concentration, and changes in behavior or personality. Diagnosis typically involves a combination of imaging tests such as MRI or CT scans and a biopsy, in which a sample of tissue from the tumor is removed for examination under a microscope. Treatment for oligodendroglioma typically involves surgery to remove as much of the tumor as possible, followed by radiation therapy and/or chemotherapy. The goal of treatment is to slow the growth of the tumor and relieve symptoms, as it is often difficult to completely eliminate the tumor. Prognosis depends on various factors such as the grade of the tumor, the location and size of the tumor, and the age and overall health of the patient.